NasdaqGS - Delayed Quote • USD
Pacific Biosciences of California, Inc. (PACB)
At close: April 18 at 4:00 PM EDT
Pre-Market: 7:03 AM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 12 | 12 | 13 | 13 |
| Avg. Estimate | -0.28 | -0.26 | -1.03 | -0.84 |
| Low Estimate | -0.32 | -0.29 | -1.11 | -0.99 |
| High Estimate | -0.24 | -0.24 | -0.93 | -0.64 |
| Year Ago EPS | -0.36 | -0.28 | -1.21 | -1.03 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 10 | 10 | 13 | 13 |
| Avg. Estimate | 44.33M | 49.72M | 211.68M | 305.45M |
| Low Estimate | 38.75M | 41.24M | 171.8M | 229.2M |
| High Estimate | 51.4M | 58.54M | 244.65M | 395M |
| Year Ago Sales | 34.38M | -- | 200.52M | 211.68M |
| Sales Growth (year/est) | 28.90% | -- | 5.60% | 44.30% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.33 | -0.32 | -0.33 | -0.28 |
| EPS Actual | -0.36 | -0.28 | -0.26 | -0.31 |
| Difference | -0.03 | 0.04 | 0.07 | -0.03 |
| Surprise % | -9.10% | 12.50% | 21.20% | -10.70% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.28 | -0.26 | -1.03 | -0.84 |
| 7 Days Ago | -0.27 | -0.26 | -1.03 | -0.86 |
| 30 Days Ago | -0.27 | -0.26 | -1.03 | -0.85 |
| 60 Days Ago | -0.27 | -0.25 | -1.01 | -0.75 |
| 90 Days Ago | -0.27 | -0.25 | -1 | -0.74 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | 3 | 5 | 4 |
| Up Last 30 Days | 3 | 4 | 6 | 4 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 3 | 2 | 2 | 2 |
Growth Estimates
| CURRENCY IN USD | PACB | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 22.20% | -- | -- | 0.80% |
| Next Qtr. | 7.10% | -- | -- | 9.60% |
| Current Year | 14.90% | -- | -- | 4.50% |
| Next Year | 18.40% | -- | -- | 13.30% |
| Next 5 Years (per annum) | -1.00% | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Upgrades & Downgrades
| Maintains | Bernstein: Outperform to Outperform | 4/18/2024 |
| Downgrade | Goldman Sachs: Buy to Neutral | 4/18/2024 |
| Maintains | Scotiabank: Sector Outperform to Sector Outperform | 4/18/2024 |
| Maintains | TD Cowen: Buy to Buy | 4/17/2024 |
| Maintains | Barclays: Equal-Weight to Equal-Weight | 4/10/2024 |
| Maintains | Goldman Sachs: Buy to Buy | 4/10/2024 |
Related Tickers
INVO INVO Bioscience, Inc.
1.5200
-16.48%
DYNT Dynatronics Corporation
0.5563
-4.91%
MGRM Monogram Orthopaedics, Inc.
2.2600
-3.83%
ABT Abbott Laboratories
105.27
-0.59%
MOTS Motus GI Holdings, Inc.
0.1735
0.00%
SINT Sintx Technologies, Inc.
0.0400
+7.24%
NNOX Nano-X Imaging Ltd.
9.07
-2.99%
TMDX TransMedics Group, Inc.
87.24
-0.71%
INSP Inspire Medical Systems, Inc.
241.15
-0.97%
CUTR Cutera, Inc.
2.3000
-3.36%